Global Near-infrared Fluorescence Imaging Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Near-infrared Fluorescence Imaging Systems Market Overview

The Near-infrared Fluorescence Imaging Systems Market was valued at USD 2.51 billion in 2025 and is projected to reach USD 5.70 billion by 2033, growing at a CAGR of 10.80% from 2026 to 2033. The Near-infrared Fluorescence Imaging Systems Market is experiencing consistent growth driven by rising demand for advanced surgical visualization technologies, increasing adoption of minimally invasive procedures, and expanding applications across oncology, cardiovascular surgery, neurosurgery, and diagnostic imaging.

The increasing prevalence of cancer and chronic diseases, combined with the growing need for precise intraoperative guidance, is encouraging hospitals and healthcare providers to adopt near-infrared fluorescence imaging systems. These systems enable real-time visualization of tissues, blood vessels, and targeted structures by using fluorescent agents, improving surgical accuracy and reducing procedural risks. Advancements in imaging technologies, development of targeted fluorescent probes, and increasing integration of AI-based image analysis are further enhancing clinical applications. In addition, rising healthcare investments, growing adoption of image-guided surgery, and increasing focus on improving patient outcomes are accelerating the adoption of near-infrared fluorescence imaging solutions across global markets.

Key Market Trends & Insights

• North America dominated the Near-infrared Fluorescence Imaging Systems Market with the largest revenue share of 39.18% in 2025, supported by advanced healthcare infrastructure, high adoption of minimally invasive surgical technologies, strong presence of medical device companies, and increasing demand for real-time intraoperative imaging solutions. The region benefits from rising adoption of fluorescence-guided surgery, increasing investments in advanced imaging technologies, and growing utilization of near-infrared systems across oncology, cardiovascular, and reconstructive surgical procedures.
• The Devices segment dominated the market with a share of 42% in 2025 due to its critical role in enabling real-time intraoperative visualization and surgical guidance .
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 9.1% from 2026 to 2033, fueled by expanding healthcare infrastructure, rising surgical volumes, increasing adoption of advanced imaging technologies, and growing investments in hospitals across China, India, Japan, and South Korea. Improving access to minimally invasive procedures and increasing healthcare modernization initiatives are further supporting regional market growth.
• The Indocyanine Green (ICG)-Based Near-infrared Fluorescence Imaging segment dominated the contrast agent category revenue share in 2025, owing to its widespread clinical application, established safety profile, and extensive use in procedures such as liver surgery, vascular imaging, lymphatic mapping, and oncology-related interventions.
• The Oncology Surgery application segment accounted for the largest revenue share in 2025, driven by increasing adoption of fluorescence imaging for tumor visualization, sentinel lymph node detection, and improved surgical margin assessment during cancer procedures.
• The Cardiovascular and Reconstructive Surgery applications are expected to witness strong growth during the forecast period, supported by increasing utilization of near-infrared fluorescence imaging for blood flow assessment, tissue perfusion monitoring, and improved surgical decision-making.
• Hospitals and Specialty Surgical Centers represent the leading end-user segment, supported by rising investments in advanced operating room technologies, increasing adoption of image-guided surgical platforms, and growing demand for precision-based surgical procedures. The expansion of minimally invasive surgery and integration of advanced imaging systems into surgical workflows are expected to further accelerate market adoption globally.

Market Size & Forecast

• Global Market Value (2025): USD 2.51 Billion
• Expected Market Value (2033): USD 5.70 Billion
• Forecast CAGR (2026–2033): 10.80%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia-Pacific

Report Scope and Near-infrared Fluorescence Imaging Systems Market Segmentation

Near-infrared Fluorescence Imaging Systems Market Trends

Trend: Rising Adoption of Near-infrared Fluorescence Imaging in Precision and Image-Guided Surgery The Near-infrared Fluorescence Imaging Systems Market is witnessing strong growth due to increasing adoption of advanced image-guided surgical technologies, rising demand for minimally invasive procedures, and growing emphasis on improving surgical accuracy. Hospitals and surgical centers are increasingly using near-infrared fluorescence imaging systems to provide real-time visualization of tissues, blood vessels, lymphatic structures, and tumor margins during complex procedures.

The increasing use of indocyanine green (ICG)-based fluorescence imaging in oncology, cardiovascular, gastrointestinal, and reconstructive surgeries is significantly contributing to market expansion. These systems enable surgeons to make more informed intraoperative decisions by improving anatomical visualization and supporting better surgical outcomes. Advancements in high-resolution imaging sensors, fluorescence-guided navigation platforms, and integration with robotic and minimally invasive surgical systems are further strengthening adoption. Research institutions and medical device companies are also expanding clinical studies focused on fluorescence-guided cancer surgery, lymphatic mapping, and perfusion assessment, creating new opportunities for near-infrared imaging technologies.

Near-infrared Fluorescence Imaging Systems Market Dynamics

Key Market Driver: Increasing Adoption of Image-Guided Surgery and Minimally Invasive Procedures

The growing demand for precision-based surgical procedures is a major driver of the Near-infrared Fluorescence Imaging Systems Market. Surgeons are increasingly adopting fluorescence imaging technologies to improve visualization during operations, particularly in oncology, cardiovascular, and reconstructive surgeries where accurate identification of tissues and blood flow is critical. The increasing global burden of cancer is further supporting adoption, as fluorescence imaging assists in tumor localization, sentinel lymph node detection, and surgical margin assessment. According to global cancer statistics, millions of new cancer cases are diagnosed annually, increasing demand for advanced surgical technologies that can improve treatment outcomes. For instance, in 2021, the U.S. Food and Drug Administration (FDA) expanded clinical acceptance of fluorescence-based imaging approaches involving indocyanine green (ICG), supporting broader use of fluorescence visualization technologies in surgical applications. Such regulatory support has encouraged medical technology companies to continue developing advanced near-infrared imaging platforms for operating rooms.

In addition, leading healthcare systems are investing in digital operating room infrastructure, robotic surgery platforms, and advanced visualization technologies, accelerating the adoption of near-infrared fluorescence imaging systems.

Key Restraint/Challenge: High Cost of Advanced Imaging Systems and Limited Adoption in Developing Healthcare Settings

A significant challenge in the Near-infrared Fluorescence Imaging Systems Market is the high cost associated with acquiring and maintaining advanced imaging platforms. These systems require specialized cameras, fluorescence imaging equipment, compatible surgical infrastructure, and trained medical professionals, increasing the overall investment required for hospitals. Smaller hospitals and healthcare facilities in cost-sensitive regions may face difficulties adopting these technologies due to budget limitations and limited availability of trained surgeons experienced in fluorescence-guided procedures. In addition, the requirement for compatible fluorescent agents, regulatory approvals, and continuous technological upgrades can increase operational costs. Although the clinical benefits of near-infrared fluorescence imaging are well recognized, reimbursement limitations and variations in healthcare infrastructure across regions can slow adoption.

Key Market Opportunity: Integration of Artificial Intelligence and Advanced Imaging Analytics

The integration of artificial intelligence (AI), machine learning, and advanced image analysis technologies presents a significant opportunity for the Near-infrared Fluorescence Imaging Systems market. AI-powered platforms can analyze fluorescence images in real time, improve tissue identification, enhance tumor detection accuracy, and assist surgeons during complex procedures. The development of AI-assisted surgical platforms, robotic surgery integration, and automated fluorescence analysis tools is expected to expand the application scope of near-infrared imaging technologies. These innovations can support faster decision-making, improve workflow efficiency, and enable more personalized surgical approaches.

For instance, in 2022, Stryker continued expanding its advanced surgical visualization technologies, including fluorescence-enabled solutions designed to support improved intraoperative visualization. Similarly, companies developing fluorescence imaging platforms are increasingly focusing on integration with minimally invasive surgery and digital operating room ecosystems. The growing adoption of precision medicine, increasing investments in cancer research, and expansion of advanced surgical capabilities in emerging markets such as China, India, and Southeast Asia are expected to create significant growth opportunities for near-infrared fluorescence imaging systems globally.

Near-infrared Fluorescence Imaging Systems Market Scope

The Near-infrared Fluorescence Imaging Systems market is segmented on the basis of type, application, end user, and indication.

• By Type

On the basis of type, the Near-infrared Fluorescence Imaging Systems Market is segmented into devices and reagents. The Devices segment dominated the market with a share of 73.42% in 2025 due to its critical role in enabling real-time intraoperative visualization and surgical guidance. Hospitals and surgical centers increasingly rely on imaging devices for cancer, cardiovascular, and minimally invasive procedures, where precision and accuracy are essential. In addition, continuous technological advancements in imaging resolution, integration with robotic-assisted surgery systems, and rising investments in advanced operating rooms are further strengthening the dominance of this segment across global healthcare systems.

The Reagents segment is expected to witness the fastest CAGR of 9.1% from 2026 to 2033, driven by increasing demand for fluorescent dyes and contrast agents used in surgical imaging procedures. Growth is supported by expanding applications in oncology, cardiovascular, and gastrointestinal surgeries, where reagents enhance visualization of tissues and blood flow. In addition, continuous development of biocompatible and targeted fluorophores, rising clinical trials for novel imaging agents, and increasing adoption in preclinical research are accelerating market expansion globally.

• By Application

On the basis of application, the Near-infrared Fluorescence Imaging Systems Market is segmented into preclinical imaging, cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic/reconstructive surgeries, and other applications. The Cancer Surgeries segment dominated the market with a share of 40.18% in 2025 due to the high global prevalence of cancer and the strong clinical need for precise tumor localization during surgery. Fluorescence imaging significantly improves surgical accuracy by enabling real-time visualization of tumor margins, reducing recurrence risks and improving patient outcomes. In addition, increasing adoption of minimally invasive oncology procedures and growing investments in advanced surgical imaging technologies are reinforcing segment dominance across hospitals and oncology centers.

The Preclinical Imaging segment is projected to witness the fastest CAGR of 9.3% from 2026 to 2033, driven by rising demand for drug discovery and translational research applications. Pharmaceutical and biotechnology companies are increasingly using near-infrared imaging for animal model studies, biomarker identification, and therapeutic evaluation. In addition, growing R&D investments, expansion of biotechnology pipelines, and increasing adoption of non-invasive imaging techniques in early-stage research are further accelerating segment growth.

• By End-User

On the basis of end-user, the Near-infrared Fluorescence Imaging Systems Market is segmented into hospitals and clinics, pharmaceutical and biotechnology companies, and research laboratories. The Hospitals and Clinics segment dominated the market with a share of 56.21% in 2025 due to the high volume of surgical procedures and increasing adoption of advanced imaging technologies in operating rooms. Hospitals are increasingly integrating fluorescence imaging systems to improve surgical precision, reduce complications, and enhance real-time decision-making in complex procedures such as oncology and cardiovascular surgeries. In addition, growing healthcare infrastructure investments and rising demand for minimally invasive surgeries are further strengthening segment dominance globally.

The Pharmaceutical and Biotechnology Companies segment is expected to witness the fastest CAGR of 9.0% from 2026 to 2033, driven by increasing use of imaging systems in drug discovery, biomarker development, and preclinical research. These companies are investing heavily in advanced molecular imaging technologies to support precision medicine and targeted therapy development. In addition, rising clinical trial activity, expansion of biotech R&D facilities, and increasing collaborations with imaging technology providers are accelerating adoption across the sector.

• By Indication

On the basis of indication, the Near-infrared Fluorescence Imaging Systems Market is segmented into cancer surgeries, cardiovascular surgeries, gastrointestinal surgeries, plastic/reconstructive surgeries, and other indications. The Cancer Surgeries segment dominated the market with a share of 39.87% in 2025 due to the rising global burden of cancer and the critical need for accurate tumor visualization during surgical procedures. Fluorescence imaging enables surgeons to identify cancerous tissues in real time, improving resection accuracy and reducing recurrence rates. In addition, increasing adoption of image-guided minimally invasive surgeries and strong clinical validation of fluorescence-based oncology procedures are supporting strong segment dominance.

The Plastic/Reconstructive Surgeries segment is expected to witness the fastest CAGR of 8.8% from 2026 to 2033, driven by increasing demand for aesthetic procedures and trauma reconstruction surgeries. Fluorescence imaging is widely used to assess tissue perfusion and viability during reconstructive procedures, improving surgical outcomes. In addition, rising cosmetic surgery demand, growing medical tourism, and advancements in microsurgical techniques are further accelerating segment growth globally.

Near-infrared Fluorescence Imaging Systems Market Regional Analysis

North America dominated the Near-infrared Fluorescence Imaging Systems Market with the largest revenue share of 39.18% in 2025, supported by advanced healthcare infrastructure, high adoption of minimally invasive surgical technologies, strong presence of medical device companies, and increasing demand for real-time intraoperative imaging solutions. The region benefits from widespread adoption of fluorescence-guided surgery, increasing investments in advanced imaging platforms, and growing utilization of near-infrared systems across oncology, cardiovascular, gastrointestinal, and reconstructive surgical procedures. The strong presence of leading healthcare institutions, advanced operating room infrastructure, and favorable adoption of image-guided surgical technologies are accelerating market growth. Increasing focus on improving surgical precision, reducing complications, and enhancing patient outcomes is encouraging hospitals and specialty centers to invest in near-infrared fluorescence imaging systems

U.S. Near-infrared Fluorescence Imaging Systems Market Insight

The U.S. Near-infrared Fluorescence Imaging Systems market is witnessing strong growth, driven by increasing adoption of fluorescence-guided surgery, rising number of minimally invasive procedures, and growing investments in advanced surgical visualization technologies. Hospitals and surgical centers across the country are increasingly integrating near-infrared imaging platforms to support tumor detection, lymphatic mapping, vascular assessment, and real-time intraoperative decision-making. The country’s advanced healthcare ecosystem, strong presence of medical technology companies, and increasing research activities in oncology and precision surgery are supporting market expansion. In addition, growing adoption of robotic-assisted surgery and digital operating room technologies is further strengthening demand for near-infrared fluorescence imaging solutions.

Europe Near-infrared Fluorescence Imaging Systems Market Insight

The Europe Near-infrared Fluorescence Imaging Systems market remains a major contributor to global revenue, supported by advanced healthcare systems, strong medical research capabilities, and increasing adoption of image-guided surgical technologies. The region is witnessing growing demand for fluorescence-based visualization solutions across oncology, cardiovascular, and reconstructive surgeries due to the need for improved surgical accuracy and enhanced patient outcomes. Increasing investments in healthcare innovation, expansion of minimally invasive procedures, and rising adoption of advanced surgical imaging platforms are supporting market growth across European countries. Collaboration between hospitals, research institutes, and medical device companies is further driving technological advancement in near-infrared imaging applications.

U.K. Near-infrared Fluorescence Imaging Systems Market Insight

The U.K. Near-infrared Fluorescence Imaging Systems market is experiencing steady growth, supported by increasing adoption of advanced surgical imaging technologies, strong clinical research activities, and rising focus on precision-based healthcare solutions. Hospitals and research centers are increasingly utilizing near-infrared fluorescence systems for applications such as cancer surgery, vascular imaging, and tissue perfusion assessment. The country’s strong healthcare infrastructure, growing investments in medical innovation, and increasing adoption of minimally invasive surgical approaches are contributing to market expansion. Furthermore, rising collaborations between academic institutions and healthcare technology companies are supporting advancements in fluorescence-guided surgical techniques.

Germany Near-infrared Fluorescence Imaging Systems Market Insight

The Germany Near-infrared Fluorescence Imaging Systems market is expanding steadily, driven by the country’s advanced healthcare infrastructure, strong medical technology sector, and increasing adoption of next-generation surgical imaging solutions. Germany’s focus on precision medicine, advanced surgical procedures, and healthcare innovation is encouraging hospitals to adopt fluorescence-guided imaging technologies.

Growing investments in oncology care, minimally invasive surgery, and digital healthcare solutions are supporting market growth. The presence of leading research institutions and medical device manufacturers further strengthens Germany’s position as a key European market for near-infrared fluorescence imaging systems.

Asia-Pacific Near-infrared Fluorescence Imaging Systems Market Insight

Asia-Pacific is expected to be the fastest-growing region in the Near-infrared Fluorescence Imaging Systems Market, registering a CAGR of 9.1% from 2026 to 2033, fueled by expanding healthcare infrastructure, rising surgical volumes, increasing adoption of advanced imaging technologies, and growing investments in hospitals across China, India, Japan, and South Korea.

 The region is witnessing increasing demand for minimally invasive procedures, improved access to advanced surgical technologies, and modernization of healthcare facilities. Growing awareness regarding precision surgery, rising prevalence of chronic diseases, and increasing investments in medical technology are accelerating adoption of near-infrared fluorescence imaging systems across hospitals and specialty centers.

Japan Near-infrared Fluorescence Imaging Systems Market Insight

The Japan Near-infrared Fluorescence Imaging Systems market is witnessing consistent growth, supported by advanced healthcare infrastructure, increasing adoption of minimally invasive surgical procedures, and strong focus on medical technology innovation. Japanese hospitals and research institutions are increasingly adopting fluorescence imaging systems for oncology, cardiovascular, and reconstructive surgery applications. The country’s aging population, rising demand for advanced surgical care, and strong emphasis on precision medicine are driving market expansion. In addition, continuous advancements in surgical robotics, imaging technologies, and healthcare digitalization are contributing to increased adoption of near-infrared fluorescence imaging systems.

China Near-infrared Fluorescence Imaging Systems Market Insight

The China Near-infrared Fluorescence Imaging Systems market is growing rapidly, driven by expanding healthcare infrastructure, increasing surgical procedures, rising adoption of minimally invasive technologies, and growing government investments in healthcare modernization. Hospitals are increasingly implementing advanced imaging solutions to improve surgical accuracy and enhance patient outcomes. China’s growing medical device industry, increasing investment in tertiary hospitals, and rising adoption of image-guided surgical techniques are supporting market growth. The increasing use of near-infrared fluorescence imaging in oncology surgeries, vascular procedures, and advanced diagnostic applications is positioning China as one of the fastest-growing markets for Near-infrared Fluorescence Imaging Systems globally.

Near-infrared Fluorescence Imaging Systems Market Share

The Near-infrared Fluorescence Imaging Systems industry is primarily led by well-established companies, including:

• Moog Inc. (U.S.)
• Dallara (Italy)
• Exail (France)
• IPG Automotive GmbH (Germany)
• aiMotive (Hungary)
• VI‑grade GmbH (Germany)
• Cruden B.V. (Netherlands)
• Dynisma Ltd. (UK)
• Applied Intuition Inc. (U.S.)
• rFpro (rFpro Limited) (England)
• Siemens AG (Germany)
• Dassault Systèmes SE (France)
• MTS Systems Corporation (U.S.)
• CAE Inc. (Canada)
• NVIDIA Corporation (U.S.)
• AB Dynamics PLC (U.K.)
• Forum8 (Japan)
• Mitsubishi Precision Co., Ltd. (Japan)
• FAAC Incorporated (U.S.)
• DriveSafety (U.S.)
• Simtec Simulation Technology GmbH (Germany)
• MB Dynamics Inc. (U.S.)
• Sanlab Simulation (India)
• SimCraft (U.S.)
• CXC Simulations (U.S.)
• XPI Simulation (United Kingdom)
• Tecknotrove Simulator Systems Pvt. Ltd. (India)
• Zhejiang Kechi Intelligent Technology Co., Ltd. (China)
• Shenzhen Zhongzhi Simulation (China)
• Hindustan Simulators (India)
• DriveSimSolutions (U.S.)
• Teksim Technologies (India)
• iMVR Inc. (U.S.)
• SimXperience (U.S.)

Latest Developments in Near-infrared Fluorescence Imaging Systems Market

• In March 2021, Stryker Corporation expanded the clinical adoption of its fluorescence-guided surgical imaging portfolio by strengthening integration of near-infrared (NIR) imaging capabilities into its endoscopy and surgical visualization systems. These systems support real-time tissue perfusion assessment and anatomical visualization during minimally invasive surgeries, particularly in oncology and gastrointestinal procedures. The expansion reflects increasing demand for image-guided surgical precision and improved intraoperative decision-making
• In September 2021, hospitals and surgical centers across North America increasingly adopted indocyanine green (ICG)-based near-infrared fluorescence imaging systems for cancer and vascular surgeries, driven by rising clinical validation and regulatory acceptance of fluorescence-guided surgery techniques. These systems improved real-time visualization of blood flow and lymphatic structures, enhancing outcomes in complex oncological and reconstructive procedures
• In April 2022, Olympus Corporation expanded its near-infrared fluorescence imaging capabilities within advanced surgical endoscopy platforms, supporting enhanced visualization during minimally invasive and robotic-assisted procedures. The development focused on improving surgical precision in oncology and gastrointestinal applications, reinforcing Olympus’ position in the global surgical imaging market through integration of fluorescence imaging into digital surgical ecosystems
• In October 2022, KARL STORZ SE & Co. KG advanced its fluorescence imaging surgical systems by integrating near-infrared visualization technologies into minimally invasive surgical platforms used in urology, gynecology, and general surgery. This development supported the broader industry shift toward hybrid imaging systems combining standard white-light imaging with real-time fluorescence guidance for improved intraoperative accuracy
• In April 2023, clinical adoption of fluorescence-guided surgery expanded globally with increased use of indocyanine green (ICG)-based near-infrared imaging systems for tumor localization, lymph node mapping, and perfusion assessment in real-time surgical environments. This growth was supported by increasing integration of fluorescence imaging into robotic-assisted surgical systems, improving precision in oncology and reconstructive procedures
• In August 2023, Medtronic strengthened its surgical visualization ecosystem by expanding integration of advanced imaging and navigation technologies used alongside fluorescence-guided surgical procedures. The development supported enhanced intraoperative decision-making in complex spinal and neurological surgeries, reflecting the broader convergence of imaging, navigation, and minimally invasive surgical technologies
• In February 2024, advancements in near-infrared fluorescence imaging research highlighted the growing role of NIR-II imaging techniques, improving tissue penetration depth and surgical visualization accuracy beyond conventional imaging limits. These innovations demonstrated potential for next-generation surgical navigation using improved signal-to-noise imaging performance, accelerating academic and clinical research in fluorescence-guided surgery
• In July 2024, leading hospitals in Europe and Asia expanded adoption of fluorescence-guided surgical imaging systems for oncology and cardiovascular procedures, supported by increasing investments in hybrid operating rooms and digital surgical infrastructure. This expansion reflects growing demand for precision surgery technologies and improved intraoperative visualization tools
• In March 2025, the global near-infrared fluorescence imaging ecosystem continued to evolve with increasing development of AI-integrated imaging platforms designed to enhance real-time interpretation of fluorescence signals during surgery. These systems are being designed to support automated tissue differentiation, tumor margin detection, and improved surgical workflow efficiency, marking a shift toward intelligent image-guided surgery systems
• In September 2025, next-generation near-infrared fluorescence imaging systems such as IC-Flow Imaging System 2.0 received regulatory clearance, supporting real-time visualization of blood flow, lymphatic structures, and tissue perfusion using indocyanine green (ICG)-based fluorescence imaging. These advancements reflect ongoing innovation in LED-based excitation systems and improved digital imaging integration for surgical applications

SKU-68836